Tango Gross Profit from 2010 to 2024

TNGX Stock

USD 3.94 0.14 3.43%

Tango Therapeutics Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Tango Therapeutics makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

-78.7 M

Current Value

-74.7 M

Quarterly Volatility

30.1 M

Credit Downgrade

Yuan Drop

Covid

Check Tango Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tango Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 M, Interest Expense of 3.6 M or Selling General Administrative of 22.1 M, as well as many indicators such as Price To Sales Ratio of 19.37, Dividend Yield of 0.0 or PTB Ratio of 6.45. Tango financial statements analysis is a perfect complement when working with Tango Therapeutics Valuation or Volatility modules.

Check out the analysis of Tango Therapeutics Correlation against competitors.

For more information on how to buy Tango Stock please use our How to Invest in Tango Therapeutics guide.

Latest Tango Therapeutics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Tango Therapeutics over the last few years. Gross profit is a required income statement account that reflects total revenue of Tango Therapeutics minus its cost of goods sold. It is profit before Tango Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Tango Therapeutics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tango Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (81.05 M)

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Gross Profit

Timeline

Tango Gross Profit Regression Statistics

	Arithmetic Mean	(10,237,030)
	Geometric Mean	11,383,493
	Coefficient Of Variation	(294.13)
	Mean Deviation	17,724,585
	Median	(6,808,000)
	Standard Deviation	30,110,335
	Sample Variance	906.6T
	Range	115.7M
	R-Value	(0.28)
	Mean Square Error	897.9T
	R-Squared	0.08
	Significance	0.31
	Slope	(1,908,668)
	Total Sum of Squares	12692.9T

Tango Gross Profit History

	2024	-74.7 M
	2023	-78.7 M
	2022	24.9 M
	2021	37 M
	2020	6 M

Other Fundumenentals of Tango Therapeutics

Gross Profit Margin

Tango Therapeutics Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Receivables	Net Invested Capital	Capital Stock	Net Working Capital	Short Term Debt	Capital Surpluse
Total Assets		0.98	0.94	-0.65	-0.85	0.96	1.0	0.92	1.0	0.98	-0.84	-0.75	-0.51	0.97	0.94	0.95	0.93	0.58
Total Stockholder Equity	0.98		0.97	-0.71	-0.82	0.92	0.97	0.84	0.98	0.96	-0.87	-0.77	-0.51	0.99	0.96	0.98	0.94	0.57
Net Tangible Assets	0.94	0.97		-0.62	-0.88	0.88	0.92	0.77	0.93	0.94	-0.87	-0.85	-0.64	0.99	0.98	0.97	0.93	0.67
Net Debt	-0.65	-0.71	-0.62		0.24	-0.48	-0.63	-0.44	-0.7	-0.54	0.86	0.54	0.03	-0.7	-0.51	-0.78	-0.56	-0.02
Retained Earnings	-0.85	-0.82	-0.88	0.24		-0.84	-0.84	-0.81	-0.81	-0.91	0.64	0.82	0.85	-0.83	-0.94	-0.76	-0.79	-0.89
Accounts Payable	0.96	0.92	0.88	-0.48	-0.84		0.97	0.94	0.95	0.94	-0.7	-0.61	-0.44	0.9	0.9	0.87	0.96	0.52
Short Term Investments	1.0	0.97	0.92	-0.63	-0.84	0.97		0.95	0.99	0.98	-0.83	-0.73	-0.5	0.95	0.93	0.93	0.92	0.57
Total Liab	0.92	0.84	0.77	-0.44	-0.81	0.94	0.95		0.91	0.91	-0.68	-0.61	-0.47	0.8	0.81	0.77	0.82	0.53
Total Current Assets	1.0	0.98	0.93	-0.7	-0.81	0.95	0.99	0.91		0.97	-0.87	-0.75	-0.48	0.97	0.93	0.96	0.92	0.54
Common Stock	0.98	0.96	0.94	-0.54	-0.91	0.94	0.98	0.91	0.97		-0.78	-0.76	-0.62	0.95	0.98	0.9	0.9	0.71
Property Plant Equipment	-0.84	-0.87	-0.87	0.86	0.64	-0.7	-0.83	-0.68	-0.87	-0.78		0.87	0.48	-0.89	-0.79	-0.94	-0.76	-0.43
Current Deferred Revenue	-0.75	-0.77	-0.85	0.54	0.82	-0.61	-0.73	-0.61	-0.75	-0.76	0.87		0.84	-0.81	-0.82	-0.81	-0.65	-0.77
Net Receivables	-0.51	-0.51	-0.64	0.03	0.85	-0.44	-0.5	-0.47	-0.48	-0.62	0.48	0.84		-0.55	-0.7	-0.47	-0.41	-0.96
Net Invested Capital	0.97	0.99	0.99	-0.7	-0.83	0.9	0.95	0.8	0.97	0.95	-0.89	-0.81	-0.55		0.96	0.99	0.94	0.59
Capital Stock	0.94	0.96	0.98	-0.51	-0.94	0.9	0.93	0.81	0.93	0.98	-0.79	-0.82	-0.7	0.96		0.91	0.91	0.77
Net Working Capital	0.95	0.98	0.97	-0.78	-0.76	0.87	0.93	0.77	0.96	0.9	-0.94	-0.81	-0.47	0.99	0.91		0.93	0.49
Short Term Debt	0.93	0.94	0.93	-0.56	-0.79	0.96	0.92	0.82	0.92	0.9	-0.76	-0.65	-0.41	0.94	0.91	0.93		0.47
Capital Surpluse	0.58	0.57	0.67	-0.02	-0.89	0.52	0.57	0.53	0.54	0.71	-0.43	-0.77	-0.96	0.59	0.77	0.49	0.47

Click cells to compare fundamentals

About Tango Therapeutics Financial Statements

Tango Therapeutics investors use historical fundamental indicators, such as Tango Therapeutics' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tango Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	-78.7 M	-74.7 M
Gross Profit Margin	(2.15)	(2.05)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Tango Stock Analysis

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC